Affymax(R) to Present at Cowen and Company Health Care Conference.PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. -- Affymax, Inc. (Nasdaq:AFFY) today announced that Arlene M. Morris, the company's president and chief executive officer, will present at the 27th Annual Cowen and Company Health Care Conference on Wednesday, March 14, 2007 at 8:00 a.m. Eastern Time in Boston. A live webcast of the presentation will be available on the Investors section of the company's website at www.affymax.com. A replay will also be available for 30 days following the presentation. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company developing novel peptide-based drugs to improve the treatment of serious and often life-threatening conditions. Affymax's lead product candidate, Hematide[TM], is currently in Phase 2 clinical trials phase 2 clinical trial Phase 2 study. See Phase study. for the treatment of anemia anemia (ənē`mēə), condition in which the concentration of hemoglobin in the circulating blood is below normal. Such a condition is caused by a deficient number of erythrocytes (red blood cells), an abnormally low level of hemoglobin associated with chronic kidney disease Chronic kidney disease (CKD), also know as chronic renal disease, is a progressive loss of renal function over a period of months or years through five stages. Each stage is a progression through an abnormally low and progressively worse glomerular filtration rate, which is and cancer. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion